Taken together, these results suggest that deletion of TAK1 has a more pronounced effect on the amelioration of HFD-induced obesity and a definitive role in improving glucose metabolism in adult mice. The gene discussed is MAP3K7; the disease is obesity due to melanocortin 4 receptor deficiency.